Subex Grants 32 Lakh ESOP Options at ₹7 Each
Subex Limited approved the grant of 32,00,000 stock options to eligible employees under its ESOP 2025. The grant price is ₹7 per option. The options are issued from the unallocated options held by the Subex Employee Welfare and ESOP Benefit Trust.
ESOP grants are standard practice for employee incentives and typically have a limited immediate impact on the company's stock price or financial performance.
The announcement is a routine ESOP grant and does not inherently contain positive or negative financial news.
Subex Limited announced on March 31, 2026, that its Nomination and Remuneration Committee (NRC) has approved the grant of 32,00,000 stock options to eligible employees under its Employee Stock Option Plan 2025 (ESOP 2025).
The grant price for these options is set at ₹7 per option. These options are being issued from the unallocated options currently held by the Subex Employee Welfare and ESOP Benefit Trust.
This action is in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
What to do with a filing like this
Subex Limited filed this with the NSE as a statutory disclosure, categorised under general announcements. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Subex Limited. Read the original for the full detail.